StockData
Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc. (PYXS) stock

PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$1.44+0.03 (+2.13%)

Close on Nov 17, 2026Market cap $120.11MP/E –Yield –

Pyxis Oncology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Pyxis Oncology's price to book ratio was 9.1× on Nov 11, 2026, against 4.7× a year earlier. Over the last 5 years it ranged from 0.2× to 18.0×, with a median of 0.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.1×+8.1
2025Dec 31, 20251.0×+0.4
2024Dec 31, 20240.6×+0.0
2023Dec 29, 20230.6×+0.3
2022Dec 30, 20220.2×–

More Pyxis Oncology figures

See a number that looks wrong?